Orexigen Therapeutics, Inc.
| Nasdaq: OREX
Orexigen Therapeutics, Inc. is a biopharmaceutical company that is engaged in the development of pharmaceutical product candidates for the treatment of obesity. Its two lead products are Contrave, which is a weight loss medication for the management of obesity and Empatic, which is an immediate release formulation, approved for the adjunctive treatment of partial seizures, a form of epilepsy. Orexigen Therapeutics was founded by Eckard Weber in September 2002 and is headquartered in La Jolla, CA.